Activation molecules (CD38 and HLA‐DR) and inhibitory molecule PD‐1 expressions on T cells were significantly higher but percentages of CD28+CD8+T cells were lower in active SLE patients compared with those in the other two groups. The gene discussed is CD28; the disease is systemic lupus erythematosus.